High rates of quinolone-resistant strains of Shigella sonnei in HIV-infected MSM

Infection

Volumn 41, Issue 5, 2013, Pages 999-1003

  Hoffmann, C ^a,b   Sahly, H ^b,c   Jessen, A ^d   Ingiliz, P ^e   Stellbrink, H J ^a   Neifer, S ^e   Schewe, K ^a   Dupke, S ^e   Baumgarten, A ^e   Kuschel, A ^f   Krznaric, I ^e  

^a Infektionsmedizinisches Centrum Hamburg   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c Labor Lademannbogen   (Germany)

^d Private Practice Dres Jessen and Colleagues   (Germany)

^e Medical Center for Infectious Diseases   (Germany)

^f Bioscientia Center for Human Genetics   (Germany)

Author keywords

HIV; Quinolones; Resistance; Shigella sonnei

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CARBAPENEM DERIVATIVE; CEFACLOR; CEFAZOLIN; CEFIXIME; CEFOTIAM; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; GENTAMICIN; LEVOFLOXACIN; MOXIFLOXACIN; O ANTIGEN; OFLOXACIN; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; TOBRAMYCIN;

ADULT; AIDS RELATED COMPLEX; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONTROLLED STUDY; DIARRHEA; FECES ANALYSIS; GERMANY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEN WHO HAVE SEX WITH MEN; MINIMUM INHIBITORY CONCENTRATION; MIXED INFECTION; NONHUMAN; OUTPATIENT; QUINOLONE RESISTANT SHIGELLA SONNEI; QUINOLONE RESISTANT SHIGELLA SONNEI INFECTION; RETROSPECTIVE STUDY; RISK FACTOR; SHIGELLA FLEXNERI; SHIGELLA SONNEI; SHIGELLOSIS; STRAIN IDENTIFICATION;

ADULT; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; DYSENTERY, BACILLARY; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; QUINOLINES; RETROSPECTIVE STUDIES; SHIGELLA SONNEI;

EID: 84885182833     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-013-0501-4     Document Type: Article

References (16)

1. Niyogi SK. Shigellosis. J Microbiol. 2005;43:133-43.
2. Niyogi SK. Increasing antimicrobial resistance - an emerging problem in the treatment of shigellosis. Clin Microbiol Infect. 2007;13:1141-3.
3. Baer JT, Vugia DJ, Reingold AL, Aragon T, Angulo FJ, Bradford WZ. HIV infection as a risk factor for shigellosis. Emerg Infect Dis. 1999;5:820-3.
4. Aragón TJ, Vugia DJ, Shallow S, Samuel MC, Reingold A, Angulo FJ, Bradford WZ. Case-control study of shigellosis in San Francisco: the role of sexual transmission and HIV infection. Clin Infect Dis. 2007;44:327-34.
5. Robert Koch Institut. Epidemiologisches Bulletin. 27 September 2010/Nr. 38. 2010.
6. Marcus U, Zucs P, Bremer V, Hamouda O, Prager R, Tschaepe H, Futh U, Kramer M. Shigellosis - a re-emerging sexually transmitted infection: outbreak in men having sex with men in Berlin. Int J STD AIDS. 2004;15:533-7.
7. Sivapalasingam S, Nelson JM, Joyce K, Hoekstra M, Angulo FJ, Mintz ED. High prevalence of antimicrobial resistance among Shigella isolates in the United States tested by the National Antimicrobial Resistance Monitoring System from 1999 to 2002. Antimicrob Agents Chemother. 2006;50:49-54.
8. Vrints M, Mairiaux E, Van Meervenne E, Collard JM, Bertrand S. Surveillance of antibiotic susceptibility patterns among Shigella sonnei strains isolated in Belgium during the 18-year period 1990 to 2007. J Clin Microbiol. 2009;47:1379-85.
9. Gu B, Cao Y, Pan S, Zhuang L, Yu R, Peng Z, Qian H, Wei Y, Zhao L, Liu G, Tong M. Comparison of the prevalence and changing resistance to nalidixic acid and ciprofloxacin of Shigella between Europe-America and Asia-Africa from 1998 to 2009. Int J Antimicrob Agents. 2012;40:9-17.
10. Gaudreau C, Ratnayake R, Pilon PA, Gagnon S, Roger M, Lévesque S. Ciprofloxacin-resistant Shigella sonnei among men who have sex with men, Canada, 2010. Emerg Infect Dis. 2011;17:1747-50.
11. Folster JP, Pecic G, Bowen A, Rickert R, Carattoli A, Whichard JM. Decreased susceptibility to ciprofloxacin among Shigella isolates in the United States, 2006 to 2009. Antimicrob Agents Chemother. 2011;55:1758-60.
12. Ruiz J, Pons MJ, Gomes C. Transferable mechanisms of quinolone resistance. Int J Antimicrob Agents. 2012;40:196-203.
13. Dalhoff A. Resistance surveillance studies: a multifaceted problem - the fluoroquinolone example. Infection. 2012;40:239-62.
14. Enders M, Turnwald-Maschler A, Regnath T. Antimicrobial resistance of Neisseria gonorrhoeae isolates from the Stuttgart and Heidelberg areas of southern Germany. Eur J Clin Microbiol Infect Dis. 2006;25:318-22.
15. Jacoby GA. Mechanisms of resistance to quinolones. Clin Infect Dis. 2005;41:S120-6.
16. World Health Organization (WHO). International note on antibiotics in the management of shigellosis. Wkly Epidemiol Rec. 2004;79:202-3.